Speaker illustration

Professor Mukul Sharma

Population Health Research Institute, Hamilton (Canada)

Member of:

European Society of Cardiology

Mike Sharma, MD MSc FRCPC, is the Director of the Stroke Program at McMaster University and Hamilton Health Sciences and holds the Michael G DeGroote Chair in Stroke Prevention, at McMaster University. His research interests include the development of new antithrombotic treatments, incorporating MRI endpoints into the design of stroke prevention trials and examining the effects of anticoagulants on stroke recurrence and covert brain infarcts. He has led trials and sub-studies including COMPASS MIND, NAVIGATE ESUS, DATAS II and currently leads the global phase II AXIOMATIC-SSP trial investigating FXI inhibition for stroke prevention in 27 countries. He has published more than 140 articles in referred journals, is the past Chair of the Canadian Stroke Consortium and established the stroke program at the University of Ottawa. Dr. Sharma is committed to developing integrated processes for stroke care and developing human and system capacity for the next generation of stroke trials.

How can targeting FXI(a) advance antithrombotic therapy for stroke prevention?

Event: ESC Congress 2023

Topic: Stroke in Atrial Fibrillation

Session type: Satellite Symposium


ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb